CMP 0.79% 31.5¢ compumedics limited

Ann: MEG FDA Approval, page-3

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 184 Posts.
    lightbulb Created with Sketch. 56
    Fantastic news......

    Highlights: • Compumedics’ Neuroscan Orion LifeSpan™ MEG receives US Food and Drug Administration (FDA) approval in the United States, following installation at Barrow Neurological Institute in Arizona, USA

    • Sites can now use the MEG for routine clinical examinations and bill for insurance reimbursement

    • Significant milestone for the company’s MEG sales and marketing efforts

    • Company continues to actively pursue forty identified MEG opportunities around the world, with four opportunities substantively advanced
 
watchlist Created with Sketch. Add CMP (ASX) to my watchlist
(20min delay)
Last
31.5¢
Change
-0.003(0.79%)
Mkt cap ! $57.88M
Open High Low Value Volume
31.5¢ 31.5¢ 30.0¢ $26.84K 85.70K

Buyers (Bids)

No. Vol. Price($)
1 20000 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
32.0¢ 14376 1
View Market Depth
Last trade - 15.56pm 18/10/2024 (20 minute delay) ?
CMP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.